Comparable stake leader
Hub Cyber Security Ltd.
SEC ownership of Evofem Biosciences, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001618835.
Disclosed value leader
Hub Cyber Security Ltd.
Comparable rows
1/12
Latest evidence
30 Jun 2026
- Public ticker
- EVFM on OTC
- Parsed ownership sources
-
13D/G and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Hub Cyber Security Ltd.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
1 of 12
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Hub Cyber Security Ltd.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001618835
- Issuer location
- San Diego, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Evofem Biosciences, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Hub Cyber Security Ltd.
Disclosed value leader
Hub Cyber Security Ltd.
Comparable rows
1/12
Latest evidence
30 Jun 2026
13D/G
3/4/5
Lead comparable stake: 10%
11 rows are not safely comparable across share classes.
13D/G row: Hub Cyber Security Ltd.
Showing 1-8 of 12 holder rows.
Quick read
Hub Cyber Security Ltd. leads the comparable SEC ownership view at 10%.
1 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Hub Cyber Security Ltd.'s linked filing trail.
Comparable ownership
Top 1
Hub Cyber Security Ltd.
10%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Hub Cyber Security Ltd. |
13D/G
|
10%
|
$147,092
14,709,204 shares
|
$0 | 30 Jun 2026 |
| Alexander A. Fitzpatrick |
3/4/5
General Counsel and Secretary
|
—
mixed-class rows
|
$19,882
816,422 shares
mixed-class rows
|
— | 18 Feb 2022 |
| Russell Barrans |
3/4/5
Chief Commercial Officer
|
—
class O/S missing
|
$17,280
448,833 shares
|
— | 08 Jul 2021 |
| Kelly Culwell |
3/4/5
Chief Medical Officer
|
—
class O/S missing
|
$10,526
273,390 shares
|
— | 20 May 2021 |
| Saundra L. Pelletier |
3/4/5
Chief Executive Officer, Director
|
—
class O/S missing
|
$7,189
186,722 shares
|
— | 31 Dec 2022 |
| Justin J. File |
3/4/5
Chief Financial Officer
|
—
class O/S missing
|
$927
24,065 shares
|
— | 31 Dec 2022 |
| Katherine Cocca Atkinson |
3/4/5
Chief Commercial Officer
|
—
class O/S missing
|
$642
16,667 shares
|
— | 31 May 2022 |
| William Walmsley Hall |
3/4/5
Director
|
—
class O/S missing
|
—
90,000 shares
|
— | 12 May 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 21 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-14 of 14 reporting-owner rows connected to Evofem Biosciences, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
14
Largest Forms 3/4/5 holder
Alexander A. Fitzpatrick
Net 12M change
$0
Latest report
12 Jan 2024
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Alexander A. Fitzpatrick | General Counsel and Secretary | $19,882 | Mixed | 18 Feb 2022 | ||
| Russell Barrans | Chief Commercial Officer | $17,280 | Mixed | 08 Jul 2021 | ||
| Kelly Culwell | Chief Medical Officer | $10,526 | Mixed | 20 May 2021 | ||
| Saundra L. Pelletier | Chief Executive Officer, Director | $7,189 | Mixed | 31 Dec 2022 | ||
| Justin J. File | Chief Financial Officer | $927 | Mixed | 31 Dec 2022 | ||
| Katherine Cocca Atkinson | Chief Commercial Officer | $642 | Mixed | 31 May 2022 | ||
| Yan Zhang | Cfo | Mixed | 12 Jan 2024 | |||
| Jenny C. Yip | Director | Mixed | 02 Aug 2022 | |||
| Gillian Greer | Director | Mixed | 04 May 2022 | |||
| William Walmsley Hall | Director | Mixed | 12 May 2021 | |||
| Anthony Stephen O'Brien | Director | Mixed | 04 May 2022 | |||
| Lisa Dale Rarick | Director | Mixed | 04 May 2022 | |||
| Colin Rutherford | Director | Mixed | 04 May 2022 | |||
| Kim P. Kamdar | Director | Mixed | 21 Dec 2023 |
Recent insider transactions for Evofem Biosciences, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.